H. Yıldız, Servet Ergün, M. Yazıcı, F. Öz, N. Ceviz
{"title":"A Case with Down Syndrome Who Developed Pericardial Tamponade due to COVID-19","authors":"H. Yıldız, Servet Ergün, M. Yazıcı, F. Öz, N. Ceviz","doi":"10.4274/cayd.galenos.2021.32448","DOIUrl":null,"url":null,"abstract":"Cardiac tamponade is a life-threatening condition that disrupts normal hemodynamics, limits the adequate filling of the heart cavities, and occurs with sudden and/or excessive fluid accumulation in the pericardial cavity. Cardiac tamponade is rare in pediatric patients and requires early diagnosis and urgent intervention. Herein, we present an 11-month-old boy with Down syndrome who developed pericardial tamponade associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and acute respiratory distress syndrome. An 11-month-old boy with Down syndrome was admitted to the pediatric infection service due to cough and respiratory distress. Pericardial effusion was detected in the follow-up of the patient whose SARS-CoV-2 polymerase chain reaction test was positive. Ibuprofen treatment was started for pericardial effusion. During the follow-up, the patient who developed respiratory distress was transferred to the intensive care unit, intubated and mechanically ventilated. In the intensive care unit, the patient developed hypotension and cardiac tamponade. An emergency pericardiocentesis was performed. Despite pericardiocentesis, the patient’s hypotension persisted. The patient died due to acute respiratory distress syndrome. Coexistence of cardiac tamponade and Coronavirus disease-2019 (COVID-19) in children has been rarely reported. We do not have enough knowledge about the course of COVID-19 in patients with Down syndrome. This case is presented in order to ensure the early recognition of similar cases in the SARS-CoV-2 pandemic and to be more careful in ARDS due to COVID-19 infection in patients with Down syndrome. © Telif Hakkı 2021 Çocuk Acil Tıp ve Yoğun Bakım Derneği.","PeriodicalId":238827,"journal":{"name":"Turkish Journal of Pediatric Emergency and Intensive Care Medicine","volume":"52 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Pediatric Emergency and Intensive Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/cayd.galenos.2021.32448","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
唐氏综合征患者因COVID-19并发心包填塞1例
心包填塞是一种危及生命的疾病,它破坏了正常的血流动力学,限制了心腔的充分充盈,并伴有心包腔内突然和/或过量的液体积聚。心脏填塞在儿科患者中很少见,需要早期诊断和紧急干预。在此,我们报告了一例11个月大的唐氏综合症男婴,他出现了与严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)和急性呼吸窘迫综合征相关的心包填塞。一名患有唐氏综合症的11个月大的男孩因咳嗽和呼吸窘迫被送进儿科感染服务部。对SARS-CoV-2聚合酶链反应阳性患者进行随访,发现心包积液。心包积液开始布洛芬治疗。随访期间,出现呼吸窘迫的患者转至重症监护病房,插管并机械通气。在重症监护病房,患者出现低血压和心脏填塞。进行紧急心包穿刺术。尽管进行了心包穿刺,患者的低血压仍持续存在。病人死于急性呼吸窘迫综合征。儿童心包填塞与冠状病毒病(COVID-19)共存的报道很少。我们对唐氏综合征患者的COVID-19病程了解不足。为了确保在SARS-CoV-2大流行中及早发现类似病例,并更加小心唐氏综合征患者因COVID-19感染而导致的ARDS。©Telif hakkyi 2021 Çocuk Acil Tıp ve Yoğun Bakım Derneği。
本文章由计算机程序翻译,如有差异,请以英文原文为准。